Cypress Capital’s Humana HUM Stock Holding History

Cypress Capital’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-5	Closed	-$2K	–	204
2021 Q2	$2K	Hold	5	–	–	﹤0.01%	68
2021 Q1	$2K	Buy	+5	New	+$2K	﹤0.01%	90

Other funds holding HUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Cypress Capital's HUM Position: Q3 2021 in Review

Cypress Capital sold out of Humana (HUM) in Q3 2021, closing a stake of 5 shares — an estimated $2K sold.

Cypress Capital first reported a position in HUM in Q1 2021 and held it in 2 quarters. The position peaked at $2K in Q2 2021. 853 funds tracked by Wall St. Rank hold HUM as of Q3 2021.

Cypress Capital reported no remaining Humana position as of Q3 2021 after selling out during the quarter.
Cypress Capital sold 5 Humana shares in Q3 2021, an estimated $2K.
Cypress Capital first reported a position in Humana in Q1 2021 and held it in 2 quarters.
Cypress Capital's Humana position peaked at $2K in Q2 2021.
853 funds tracked by Wall St. Rank held Humana as of Q3 2021.

Based on Cypress Capital's 13F filing for Q3 2021, filed 10 Feb 2022.